NCT03427229View on ClinicalTrials.gov

Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions
Clostridium DifficilePseudomembranous Colitis
Interventions
BIOLOGICAL

Single-infusion FMT

Patients will receive a single fecal infusion by colonoscopy

DRUG

Vancomycin (before randomization)

Vancomycin is administered in all patients for 3 days before randomization. Then vancomycin is stopped and patients are randomized to single-infusion FMT or multiple-infusion FMT.

BIOLOGICAL

multiple-infusion FMT

Patients will receive multiple fecal infusions by colonoscopy

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT03427229 - Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection | Biotech Hunter | Biotech Hunter